John Raffalli is an Infectious Disease physician affiliated with New York Medical College. OpenAlex indexes 20 publications with 2,437 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Mount Kisco Medical Group, Pc
90 South Bedford Road
Mount Kisco, NY 105493412
Telephone
914-241-1050Registry record last updated 13 Jun 2016.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Baxter HealthcareProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
51.5%Macrolide Antimicrobial12.7%Azithromycin100%Part D≥29 patientsTetracycline-class Drug10.9%Doxycycline Hyclate100%Part D<11 patients+ 4 more classes in this area
Cardiovascular
31%Statin16.2%Atorvastatin Calcium100%Part D≥15 patientsCalcium channel blocker7.9%Amlodipine Besylate100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
11.8%Proton pump inhibitor11.8%Omeprazole56%Pantoprazole Sodium44%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis
Diagnostic Microbiology and Infectious Disease
2016 - International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia
European Journal of Clinical Microbiology & Infectious Diseases
2006 - International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia
European Journal of Clinical Microbiology & Infectious Diseases
2005 - Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
New England Journal of Medicine
2002
Similar KOLs
Other experts from the same institution or the same specialty.
Mitchell Cairo, MD
New York Medical College
Leslie Citrome, MD, MPH
New York Medical College
Jerry Nadler
New York Medical College
Diwakar Jain, MD
New York Medical College
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”